Sp132

PANEL DISCUSSION

Date
May 18, 2024

Presenters

Speaker Image for Lin Chang
Speaker Image for Baha Moshiree
Atrium Health
Speaker Image for Arjan Bredenoord
Amsterdam UMC, University of Amsterdam

Tracks

Related Products

Thumbnail for Improving our Understanding in Pathogenesis and Therapeutics in Eosinophilic Esophagitis
Improving our Understanding in Pathogenesis and Therapeutics in Eosinophilic Esophagitis
SOCIETY: AGA Pathophysiologic advances with management implications in eosinophilic esophagitis
Thumbnail for TREATMENT WITH THE HISTAMINE 1 RECEPTOR ANTAGONIST EBASTINE FOR NON-CONSTIPATED IRRITABLE BOWEL SYNDROME: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL
TREATMENT WITH THE HISTAMINE 1 RECEPTOR ANTAGONIST EBASTINE FOR NON-CONSTIPATED IRRITABLE BOWEL SYNDROME: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL
Our previous pilot study showed that treatment with the histamine 1 receptor antagonist ebastine improved symptoms in patients with irritable bowel syndrome (IBS)…
Thumbnail for ENDOSCOPIC VS. SURGICAL MYOTOMY IN PATIENTS WITH IDIOPATHIC ACHALASIA – FIVE-YEAR FOLLOW UP OF A RANDOMISED TRIAL
ENDOSCOPIC VS. SURGICAL MYOTOMY IN PATIENTS WITH IDIOPATHIC ACHALASIA – FIVE-YEAR FOLLOW UP OF A RANDOMISED TRIAL
Endoscopic myotomy (POEM) was shown equally effective as laparoscopic Heller myotomy (LHM) in patients with achalasia at two years in a multicenter randomized trial. Postprocedural reflux esophagitis and treatment with acid inhibitors were more frequent after POEM…
Thumbnail for Functional Dyspepsia and Nausea and Vomiting
Functional Dyspepsia and Nausea and Vomiting
SOCIETY: AGA This session will help attendees understand the diagnosis and treatment of functional dyspepsia and nausea and vomiting…